(Q44872781)

English

Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity

scientific article published on 30 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

phosphorylation

1 reference

based on heuristic

inferred from title

B-cell lymphoma

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Starczynowski DT

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Trautmann H

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Pott C

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Harder L

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Africa JA

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Leeman JR

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Siebert R

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Gilmore TD

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

30 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

2685-2694

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210089

0 references

Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

The c-Rel transcription factor and B-cell proliferation: a deal with the devil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Jesterone dimer, a synthetic derivative of the fungal metabolite jesterone, blocks activation of transcription factor nuclear factor kappaB by inhibiting the inhibitor of kappaB kinase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Mining for regulatory programs in the cancer transcriptome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

IkappaB kinase complexes: gateways to NF-kappaB activation and transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Stimulation of c-Rel transcriptional activity by PKA catalytic subunit beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Tumor Necrosis Factor-α Activation of NF-κB Requires the Phosphorylation of Ser-471 in the Transactivation Domain of c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

21 January 2018

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional genomic analysis reveals distinct neoplastic phenotypes associated with c-myb mutation in the bursa of Fabricius

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210089

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210089

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44872781&oldid=2054798706"